Biosyent Inc - ESG Rating & Company Profile powered by AI
The ESG rating includes seventeen UN SDGs including: 'Clean Water & Sanitation', 'Reduced Inequalities' and 'Partnerships for the Goals'. If you are employed by Biosyent Inc and you would like to use your ESG rating, please get in touch. Alternative companies in the rating industry group for Biosyent Inc are shown.
Biosyent Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.9; made up of an environmental score of 4.0, social score of 4.0 and governance score of 3.4.
3.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1443 | XSpray Pharma AB (publ) | 4.0 | High |
| 1443 | Zhong Yuan Bio-Technology Holdings Ltd | 4.0 | High |
| ... | ... | ... | |
| 1476 | Biosyent Inc | 3.9 | Medium |
| 1476 | Anebulo Pharmaceuticals Inc | 3.9 | Medium |
| 1476 | Anhui Sunhere Pharmaceutical Excipients Co Ltd | 3.9 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Biosyent Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Biosyent Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Biosyent Inc report the average age of the workforce?
Sign up for free to unlockDoes Biosyent Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Biosyent Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Biosyent Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Biosyent Inc offer flexible work?
Sign up for free to unlockDoes Biosyent Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Biosyent Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Biosyent Inc conduct supply chain audits?
Sign up for free to unlockDoes Biosyent Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Biosyent Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Biosyent Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Biosyent Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Biosyent Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Biosyent Inc disclose water use targets?
Sign up for free to unlockDoes Biosyent Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Biosyent Inc have a product recall in the last two years?
Sign up for free to unlockDoes Biosyent Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Biosyent Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Biosyent Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Biosyent Inc disclose parental leave metrics?
Sign up for free to unlockDoes Biosyent Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Biosyent Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Biosyent Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Biosyent Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Biosyent Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Biosyent Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Biosyent Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Biosyent Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Biosyent Inc disclose its waste policy?
Sign up for free to unlockDoes Biosyent Inc report according to TCFD requirements?
Sign up for free to unlockDoes Biosyent Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Biosyent Inc disclose energy use targets?
Sign up for free to unlockDoes Biosyent Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Biosyent Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Biosyent Inc
These potential risks are based on the size, segment and geographies of the company.
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia. It also offers Cathejell, a product indicated for surface anesthesia and lubrication during various procedures, including cystoscopy, catheterization, endourethral operation, endoscopy, proctoscopy, rectoscopy, and tracheal intubation, as well as used for the symptomatic treatment of pain in connection with cystitis and urethritis; Aguettant System for pre-filled syringes that are used for various injectable medications in hospital and acute care settings; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by menopause, stress, and chemotherapy; Proktis-M, a rectal suppository for the healing of the anus and rectum; and Cysview, an adjunct to white-light cystoscopy for the detection and management of non-muscle invasive papillary bladder cancer. In addition, it provides Combogesic for moderate acute pain and reduction of fever in adults; Protect-It, a non-chemical food-safe grain insecticide product used as a preventative treatment against insect infestations in stored grains; and Tibella, a hormone replacement therapy to treat vasomotor symptoms due to estrogen deficiency. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BioSyent Inc. was incorporated in 2006 and is headquartered in Mississauga, Canada.